Envista (NYSE:NVST) Rating Increased to Strong-Buy at Baird R W

Envista (NYSE:NVST - Get Free Report) was upgraded by Baird R W from a "hold" rating to a "strong-buy" rating in a research report issued on Tuesday,Zacks.com reports.

A number of other equities research analysts also recently weighed in on the stock. Robert W. Baird upgraded shares of Envista from a "neutral" rating to an "outperform" rating and lifted their price target for the company from $21.00 to $23.00 in a research report on Tuesday. Morgan Stanley set a $16.00 price target on Envista in a research report on Tuesday, April 15th. Wells Fargo & Company set a $19.00 price objective on shares of Envista in a research report on Saturday, March 8th. JPMorgan Chase & Co. cut their price target on Envista from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Thursday, March 6th. Finally, Bank of America cut their price target on Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $20.23.

Envista Stock Down 0.9%

Shares of NYSE:NVST traded down $0.17 during midday trading on Tuesday, reaching $18.29. The company had a trading volume of 2,560,792 shares, compared to its average volume of 2,572,221. Envista has a 1-year low of $14.22 and a 1-year high of $23.00. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The business's 50 day moving average price is $16.64 and its 200 day moving average price is $18.76. The stock has a market cap of $3.10 billion, a PE ratio of -2.82, a P/E/G ratio of 1.27 and a beta of 0.97.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. The company had revenue of $616.90 million during the quarter, compared to analysts' expectations of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The business's revenue was down 1.1% on a year-over-year basis. During the same period last year, the firm posted $0.26 earnings per share. Research analysts forecast that Envista will post 1 EPS for the current fiscal year.

Institutional Trading of Envista

A number of large investors have recently added to or reduced their stakes in the stock. Ariel Investments LLC increased its holdings in Envista by 0.7% in the 1st quarter. Ariel Investments LLC now owns 12,144,745 shares of the company's stock worth $209,618,000 after acquiring an additional 85,121 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Envista by 24.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company's stock worth $144,760,000 after buying an additional 1,625,206 shares during the period. Franklin Resources Inc. raised its holdings in Envista by 72.6% during the 4th quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock valued at $132,223,000 after acquiring an additional 2,882,844 shares during the period. Gates Capital Management Inc. lifted its position in shares of Envista by 10.0% during the first quarter. Gates Capital Management Inc. now owns 5,163,745 shares of the company's stock worth $89,126,000 after acquiring an additional 469,597 shares in the last quarter. Finally, Clarkston Capital Partners LLC boosted its holdings in shares of Envista by 9.3% in the first quarter. Clarkston Capital Partners LLC now owns 4,686,747 shares of the company's stock worth $80,893,000 after acquiring an additional 398,672 shares during the period.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.